First COVID-19 vaccine human trial finds it is safe
Beijing, May 23 (PTI) The first COVID-19 vaccine to reach phase I clinical trial is safe, well-tolerated, and capable of generating an immune response against the novel coronavirus in humans, says a new research published in The Lancet journal.
According to the study of 108 adults, the vaccine produced neutralising antibodies, and a response mediated by the immune system's T-cells against the novel coronavirus, SARS-CoV-2.
- Read more about First COVID-19 vaccine human trial finds it is safe
- Log in or register to post comments